IGF1 and obesity disorder: Insulin resistance associated with obesity results in elevated insulin and insulin-like growth factor 1 (IGF-1) levels, which activate PI3K-AKT and (Mitogen-Activated Protein Kinase) MAPK signaling pathways critical for cell proliferation and survival.